Cocrystal Pharma, Inc.
- Last sale
- Nov 12, 2026 · -3.33%
- Market cap
- $19.55M
- 19.26M shares
- Filings
- 674
Q2 2026−69.3% FY20 yoy
Q2 2026N/M FY25 yoy
Q2 2026N/M FY25 yoy
FY 2025derivedN/M FY25 yoy
Q2 2026N/M FY25 yoy
FY 2025−28.8% FY25 yoy
- $19.55M
- —
- —
- 18.7×
- -41.96%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2020 | 2020-12-31 | $2,014,000 | reported | |
| FY 2019 | 2019-12-31 | $6,564,000 | reported | |
| FY 2011 | 2011-12-31 | $12,712,091 | reported |
Pharmaceutical preparations
Cocrystal Pharma, Inc. is the 388th largest of the 554 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
TXMDTherapeuticsMD, Inc.$3.0M71.6%18.8%$20.9MEDSAEdesa Biotech, Inc.———$20.1MKYNBKyntra Bio, Inc.$6.4M78.3%2,848.6%$19.6M
COCPCocrystal Pharma, Inc. (this company)———$19.6M
ATOSAtossa Therapeutics, Inc.———$19.5MAYTUAytu Biopharma, Inc$57.6M13.3%24.8%$19.4MBIOEBio Essence Corp$1.9M485.8%47.2%$19.0MXTLBXTL Biopharmaceuticals LtdFiscal 2024 figures———$18.1MLPCNLipocine Inc.$2.0M82.3%487.1%$17.9MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Cocrystal Pharma, Inc. · CIK 1412486 · Engraved from SEC EDGAR